Business Description
TheraVet SA
ISIN : BE0974387194
Share Class Description:
XPAR:ALVET: Ordinary SharesCompare
Compare
Traded in other countries / regions
ALVET.France31A.Germany IPO Date
2021-06-17Description
TheraVet SA is a vet biotech company. Its mission is to develop, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases. Its main targets are osteoarthritis, ligament & tendon injuries, and bone surgery in cats and dogs as well as horses.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.99 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -2.21 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.86 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3 | |||||
3-Year EBITDA Growth Rate | -17.7 | |||||
3-Year EPS without NRI Growth Rate | -61.1 | |||||
3-Year FCF Growth Rate | -53.2 | |||||
3-Year Book Growth Rate | 21.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 2.27 | |||||
9-Day RSI | 4.68 | |||||
14-Day RSI | 7.03 | |||||
6-1 Month Momentum % | -57.2 | |||||
12-1 Month Momentum % | -67.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.4 | |||||
Quick Ratio | 3.15 | |||||
Cash Ratio | 2.37 | |||||
Days Inventory | 25.48 | |||||
Days Sales Outstanding | 7 | |||||
Days Payable | 28.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.37 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -49.26 | |||||
Operating Margin % | -201.76 | |||||
Net Margin % | -145.73 | |||||
FCF Margin % | -156.03 | |||||
ROE % | -23.37 | |||||
ROA % | -18.86 | |||||
ROIC % | -33.73 | |||||
ROC (Joel Greenblatt) % | -6272.37 | |||||
ROCE % | -20.8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.36 | |||||
PB Ratio | 0.24 | |||||
Price-to-Tangible-Book | 1.76 | |||||
EV-to-EBIT | -0.93 | |||||
EV-to-EBITDA | -2.82 | |||||
EV-to-Revenue | 1.37 | |||||
EV-to-FCF | -0.88 | |||||
Price-to-Net-Current-Asset-Value | 9.1 | |||||
Earnings Yield (Greenblatt) % | -107.53 | |||||
FCF Yield % | -114.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TheraVet SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.078 | ||
EPS (TTM) (€) | -0.487 | ||
Beta | 0.39 | ||
Volatility % | 82.21 | ||
14-Day RSI | 7.03 | ||
14-Day ATR (€) | 0.025325 | ||
20-Day SMA (€) | 0.50835 | ||
12-1 Month Momentum % | -67.42 | ||
52-Week Range (€) | 0.45 - 2.4 | ||
Shares Outstanding (Mil) | 3.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TheraVet SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TheraVet SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
TheraVet SA Frequently Asked Questions
What is TheraVet SA(XPAR:ALVET)'s stock price today?
The current price of XPAR:ALVET is €0.46. The 52 week high of XPAR:ALVET is €2.40 and 52 week low is €0.45.
When is next earnings date of TheraVet SA(XPAR:ALVET)?
The next earnings date of TheraVet SA(XPAR:ALVET) is .
Does TheraVet SA(XPAR:ALVET) pay dividends? If so, how much?
TheraVet SA(XPAR:ALVET) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |